ACS Omega
(Feb 2024)
Targeted Delivery of Gemcitabine for Precision Therapy of Cholangiocarcinoma Using Hyaluronic Acid-Modified Metal–Organic Framework Nanoparticles
- Chuan Long,
- Han Peng,
- Wei Yang,
- Min Wang,
- Bo Luo,
- Jie Hao,
- Yan Dong,
- Wenwei Zuo
Affiliations
- Chuan Long
- Department of Otolaryngology, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
- Han Peng
- Department of Oncology, Southwest Hospital, Army Medical University, Chongqing, China
- Wei Yang
- Department of Radiology, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
- Min Wang
- Department of General Surgery, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
- Bo Luo
- Department of General Surgery, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
- Jie Hao
- Department of Oncology, Southwest Hospital, Army Medical University, Chongqing, China
- Yan Dong
- Department of Oncology, Southwest Hospital, Army Medical University, Chongqing, China
- Wenwei Zuo
- Department of General Surgery, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
- DOI
-
https://doi.org/10.1021/acsomega.3c09751
- Journal volume & issue
-
Vol. 9,
no. 10
pp.
11998
– 12005
WeChat QR code